Prostate News Archive
24-Jun-2008
State-of-the-Art Lecture: Immune-Based Approaches To Prostate Cancer - Reported From The Annual Meeting Of The ... (Medical News Today)
ORLANDO, FL (UroToday.com) - Dr. Drake, a medical oncologist from Johns Hopkins discussed use of the immune system to combat CaP. ProVenge and GVAX immunotherapy were discussed. Both have reached phase III clinical trials. The immune system uses the CD8 killer T cell to respond to cancer. There are 1010 possible receptors to target immune therapies. Prostate Breast Melanoma intravenous trial update (VLA.AX, 00853585, 20080624) (Huntleys' Stock of the Week via Yahoo!7 Finance)
mktsens Y npages 1 filelink s=VLA.AX&f=00853585&d=20080624 Urologists Identify Seven Biomarkers That May Help Pinpoint Prostate Cancer Recurrence (Science Daily)
A simple blood test may help doctors better predict whether prostate cancer will recur or spread in patients who have undergone surgery for the disease, researchers have found. Poorer Patients Have Poorer Survival After Cancer Diagnosis (HealthCentral.com)
Copyright © 2008 ScoutNews LLC. All rights reserved. MONDAY, June 23 (HealthDay News) -- Low socioeconomic status increases a cancer patient's risk of dying, say U.S. researchers who analyzed data on almost 14,000 breast, prostate and colorectal patients in seven states. Seven biomarkers that may help pinpoint prostate cancer recurrence found (News-Medical-Net)
A simple blood test may help doctors better predict whether prostate cancer will recur or spread in patients who have undergone surgery for the disease, UT Southwestern Medical Center researchers have found.
Back to Prostate News Archive
